Hypoxia Inducible Factor-1α Regulates the Migration of Bone Marrow Mesenchymal Stem Cells Via Integrin α 4
Overview
Affiliations
Although hypoxic environments have been known to regulate the migratory ability of bone marrow-derived mesenchymal stem cells (BM-MSCs), which is a critical factor for maximizing the therapeutic effect, the underlying mechanisms remain unclear. Therefore, we aimed to confirm the effect of hypoxia-inducible factor-1α (HIF-1α) on the migration of BM-MSCs and to analyze the interaction between HIF-1α and integrin-mediated signals. Hypoxia-activated HIF-1α significantly increased BM-MSC migration. The expression of integrin α 4 was decreased in BM-MSCs by increased HIF-1α under hypoxia, whereas the expression of Rho-associated kinase 1 (ROCK1) and Rac1/2/3 was increased. After downregulation of HIF-1α by YC-1, which is an inhibitor of HIF-1α, BM-MSC migration was decreased via upregulation of integrin α 4 and downregulation of ROCK1 and Rac1/2/3. Knockdown of integrin α 4 by integrin α 4 siRNA (siITGA4) treatment increased BM-MSC migration by upregulation of ROCK1, Rac1/2/3, and matrix metalloproteinase-2 regardless of oxygen tension. Moreover, siITGA4 treatment increased HIF-1α expression and augmented the translocation of HIF-1α into the nucleus under hypoxia. Taken together, the alternative expression of HIF-1α induced by microenvironment factors, such as hypoxia and integrin α 4, may regulate the migration of BM-MSCs. These findings may provide insights to the underlying mechanisms of BM-MSC migration for successful stem cell-based therapy.
Jiang Z, Chen L, Huang L, Yu S, Lin J, Li M Int J Nanomedicine. 2024; 19:7751-7773.
PMID: 39099796 PMC: 11297574. DOI: 10.2147/IJN.S455469.
PSMD12 promotes non-small cell lung cancer progression through activating the Nrf2/TrxR1 pathway.
Lv J, Ma S, Wang X, Dang J, Ma F Genes Genomics. 2024; 46(3):263-277.
PMID: 38243044 DOI: 10.1007/s13258-023-01484-5.
Designing Olfactory Ensheathing Cell Transplantation Therapies: Influence of Cell Microenvironment.
Murtaza M, Mohanty L, Ekberg J, St John J Cell Transplant. 2022; 31:9636897221125685.
PMID: 36124646 PMC: 9490465. DOI: 10.1177/09636897221125685.
Mesenchymal Stem Cells for Neurological Disorders.
Andrzejewska A, Dabrowska S, Lukomska B, Janowski M Adv Sci (Weinh). 2021; 8(7):2002944.
PMID: 33854883 PMC: 8024997. DOI: 10.1002/advs.202002944.
The Gastrointestinal Tumor Microenvironment: An Updated Biological and Clinical Perspective.
Batista S, Gregorio A, Otake A, Couto N, Costa-Silva B J Oncol. 2019; 2019:6240505.
PMID: 31885581 PMC: 6893275. DOI: 10.1155/2019/6240505.